SOON, SKINNINESS WILL BE PLEBEIAN AGAIN: GLP-1 hybrid drug being tested as weight-loss aid. “People who took the drug amycretin lost up to 13% of their body weight over three months, according to early clinical trial results presented at the European Association for the Study of Diabetes annual meeting in Madrid.”